Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-15-021125
Filing Date
2015-06-22
Accepted
2015-06-22 16:15:02
Documents
2
Period of Report
2015-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3049
2 POWER OF ATTORNEY (PUBLIC): POWER OR ATTORNEY doc1.txt EX-24 4199
  Complete submission text file 0001127602-15-021125.txt   8883
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 15944956